Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure - PubMed (original) (raw)
. 2001 Nov 23;276(47):44284-96.
doi: 10.1074/jbc.M105343200. Epub 2001 Sep 11.
Affiliations
- PMID: 11553618
- DOI: 10.1074/jbc.M105343200
Free article
Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure
V N Uversky et al. J Biol Chem. 2001.
Free article
Abstract
Parkinson's disease involves the aggregation of alpha-synuclein to form fibrils, which are the major constituent of intracellular protein inclusions (Lewy bodies and Lewy neurites) in dopaminergic neurons of the substantia nigra. Occupational exposure to specific metals, especially manganese, copper, lead, iron, mercury, zinc, aluminum, appears to be a risk factor for Parkinson's disease based on epidemiological studies. Elevated levels of several of these metals have also been reported in the substantia nigra of Parkinson's disease subjects. We examined the effect of various metals on the kinetics of fibrillation of recombinant alpha-synuclein and in inducing conformational changes, as monitored by biophysical techniques. Several di- and trivalent metal ions caused significant accelerations in the rate of alpha-synuclein fibril formation. Aluminum was the most effective, along with copper(II), iron(III), cobalt(III), and manganese(II). The effectiveness correlated with increasing ion charge density. A correlation was noted between efficiency in stimulating fibrillation and inducing a conformational change, ascribed to formation of a partially folded intermediate. The potential for ligand bridging by polyvalent metal ions is proposed to be an important factor in the metal-induced conformational changes of alpha-synuclein. The results indicate that low concentrations of some metals can directly induce alpha-synuclein fibril formation.
Similar articles
- Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease.
Uversky VN, Li J, Bower K, Fink AL. Uversky VN, et al. Neurotoxicology. 2002 Oct;23(4-5):527-36. doi: 10.1016/s0161-813x(02)00067-0. Neurotoxicology. 2002. PMID: 12428725 - Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.
Uversky VN, Li J, Souillac P, Millett IS, Doniach S, Jakes R, Goedert M, Fink AL. Uversky VN, et al. J Biol Chem. 2002 Apr 5;277(14):11970-8. doi: 10.1074/jbc.M109541200. Epub 2002 Jan 25. J Biol Chem. 2002. PMID: 11812782 - Methionine oxidation, alpha-synuclein and Parkinson's disease.
Glaser CB, Yamin G, Uversky VN, Fink AL. Glaser CB, et al. Biochim Biophys Acta. 2005 Jan 17;1703(2):157-69. doi: 10.1016/j.bbapap.2004.10.008. Epub 2004 Nov 25. Biochim Biophys Acta. 2005. PMID: 15680224 Review. - Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
Hegde ML, Jagannatha Rao KS. Hegde ML, et al. Arch Biochem Biophys. 2003 Oct 15;418(2):169-78. doi: 10.1016/j.abb.2003.08.015. Arch Biochem Biophys. 2003. PMID: 14522588 Review.
Cited by
- Iron accumulation in Parkinson's disease.
Mochizuki H, Yasuda T. Mochizuki H, et al. J Neural Transm (Vienna). 2012 Dec;119(12):1511-4. doi: 10.1007/s00702-012-0905-9. Epub 2012 Oct 16. J Neural Transm (Vienna). 2012. PMID: 23070727 Review. - SERF protein is a direct modifier of amyloid fiber assembly.
Falsone SF, Meyer NH, Schrank E, Leitinger G, Pham CL, Fodero-Tavoletti MT, Holmberg M, Dulle M, Scicluna B, Gesslbauer B, Rückert HM, Wagner GE, Merle DA, Nollen EA, Kungl AJ, Hill AF, Cappai R, Zangger K. Falsone SF, et al. Cell Rep. 2012 Aug 30;2(2):358-71. doi: 10.1016/j.celrep.2012.06.012. Epub 2012 Jul 26. Cell Rep. 2012. PMID: 22854022 Free PMC article. - Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.
Garcia-Garcia A, Zavala-Flores L, Rodriguez-Rocha H, Franco R. Garcia-Garcia A, et al. Antioxid Redox Signal. 2012 Dec 15;17(12):1764-84. doi: 10.1089/ars.2011.4501. Epub 2012 May 3. Antioxid Redox Signal. 2012. PMID: 22369136 Free PMC article. Review. - Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naïve Parkinson's disease.
Kim JE, Lee HS, Jang W. Kim JE, et al. Front Aging Neurosci. 2023 Nov 2;15:1282367. doi: 10.3389/fnagi.2023.1282367. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38020782 Free PMC article. - Intranasal exposure to manganese disrupts neurotransmitter release from glutamatergic synapses in the central nervous system in vivo.
Moberly AH, Czarnecki LA, Pottackal J, Rubinstein T, Turkel DJ, Kass MD, McGann JP. Moberly AH, et al. Neurotoxicology. 2012 Oct;33(5):996-1004. doi: 10.1016/j.neuro.2012.04.014. Epub 2012 Apr 20. Neurotoxicology. 2012. PMID: 22542936 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous